EP 1618213 A2 20060125 - FANCC, DAD1, GRIM19 AND HADHII GENES OF PSORIASIS
Title (en)
FANCC, DAD1, GRIM19 AND HADHII GENES OF PSORIASIS
Title (de)
FANCC, DAD1, GRIM19 UND HADHII ALS PSORIASIS MARKERGENE
Title (fr)
GENES FANCC, DAD1, GRIM19 ET HADHII MARQUEURS DU PSORIASIS
Publication
Application
Priority
- FR 2004000934 W 20040415
- FR 0304773 A 20030416
Abstract (en)
[origin: FR2853910A1] Use of a polynucleotide probe (A) of 10-500 bp and at least 80% complementary with a target corresponding to all or part of the FANCC (Fanconi anemia, complementation group C) gene (NM 000136.1) (a) for characterizing a biological sample by measuring the level of FANCC or (b) for identifying compounds (I) for treatment of psoriasis. Independent claims are also included for the following: (1) method for identifying (I); (2) research tool or diagnostic kit that comprises (A); (3) method for diagnosing psoriasis, or a predisposition to it, by measuring overexpression of FANCC, by contacting a test sample with (A). ACTIVITY : Antipsoriatic. No details of tests for antipsoriatic activity are given. MECHANISM OF ACTION : RNAi; RNA interference; Antisense oligonucleotide inhibitor.
IPC 1-7
IPC 8 full level
C12Q 1/68 (2006.01)
CPC (source: EP US)
C12Q 1/6883 (2013.01 - EP US); C12Q 2600/158 (2013.01 - EP US)
Citation (search report)
See references of WO 2004094661A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
FR 2853910 A1 20041022; FR 2853910 B1 20070824; CA 2522120 A1 20041104; EP 1618213 A2 20060125; US 2006115836 A1 20060601; WO 2004094661 A2 20041104; WO 2004094661 A3 20051013
DOCDB simple family (application)
FR 0304773 A 20030416; CA 2522120 A 20040415; EP 04742515 A 20040415; FR 2004000934 W 20040415; US 24930505 A 20051014